Dexamethasone palmitate
PreclinicalSmall molecule
Dexamethasone palmitate is one of 60 small molecule programs targeting Post Operative Nausea and Vomiting. It is currently in Preclinical.
2
Indications
8
Total Trials
4
Active Trials
59
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
193 competitors in Chronic Pain
#DrugCompanyPhaseTrials
1Nucynta
CCollegium Pharmaceutical, Inc.
Phase 3
Tramadol Plus Acetaminophen
Johnson & JohnsonPhase 3
Adezunap
AApurano Pharmaceuticals GmbH
Phase 3
Naloxone Hydrochloride
PPurdue Pharma LP
Phase 3
BEMA Fentanyl
BBioDelivery Sciences International
Phase 3
MS Contin
Merck & Co.Preclinical
Oravescent Fentanyl
CCephalon
Phase 3
Cymbalta
Alnylam PharmaceuticalsPreclinical
Dayvigo
EisaiPreclinical
Intuniv
PPromius Pharma, LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Dexamethasone Palmitate4 trials
Dexamethasone Palmitate for PONV After Open Surgery
Recruiting·—·N/A·NCT06997419·500 enrolled
Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery
Completed·—·Phase 4·NCT05693467·124 enrolled
Dexamethasone Palmitate for PONV After Craniotomy
Recruiting·—·N/A·NCT06988124·500 enrolled
Show 1 more trial
Dexamethasone Palmitate for Postoperative Pain
Not yet recruiting·—·N/A·NCT07341854·446 enrolled
Dexamethasone1 trial
REDUCE Trial: Perineural Dexamethasone on Scalp Nerve Blocks
Completed·—·N/A·NCT04648358·156 enrolled
Post-craniotomy1 trial
Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-craniotomy Pain
Unknown status·—·Phase 4·NCT04488315·130 enrolled
Chronic pain1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Dexamethasone palmitate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- XXijing Hospital